Skip to main content

BARCLAYS PLC

Position in ESPR — Esperion Therapeutics, Inc.

CIK 312069 LONDON, X0

Position in ESPR

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$0
+$0 QoQ
Shares Held
207,293
-84.1% QoQ
Ownership
0.081%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ESPR Over Time

Shares Held

Position Value (USD)

Derivatives in ESPR

reported options exposure · as of Mar 31, 2020
CallValue
$0
CallShares
100
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

BARCLAYS PLC holds $487,957,812 across 61 Drug Manufacturers - Specialty & Generic names. ESPR ranks #61 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ESPR

Export CSV
27 filing rows on record
Report Date Value (USD) Shares
2026-06-30 207,293
2026-03-31 1,301,911
2025-12-31 443,339
2025-09-30 335,609
2025-06-30 361,709
2025-03-31 236,133
2024-12-31 359,235
2024-09-30 309,671
2024-06-30 155,162
2024-03-31 104,484
2023-12-31 121,084
2023-09-30 88,984
2023-06-30 103,648
2023-03-31 160,427
2022-12-31 163,021
2022-09-30 41,696
2022-06-30 28,079
2022-03-31 35,062
2021-12-31 95,698
2021-09-30 48,606
2021-06-30 34,306
2021-03-31 38,020
2020-12-31 55,625
2020-09-30 11,861
2020-06-30 185,193
2020-03-31 100
2020-03-31 179,208